Celexa vs. Fluoxetine

See how Celexa and Fluoxetine compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Celexa and Fluoxetine are both SSRIs for major depressive disorder, but Fluoxetine has FDA approval for more conditions, including OCD, bulimia nervosa, and pediatric depression.

  • Celexa's dose is capped at 40 mg daily because of a dose-dependent QT prolongation risk, while Fluoxetine can be titrated up to 80 mg daily or given as a once-weekly 90 mg maintenance dose.

  • Both carry a boxed warning for increased suicidal thinking in children, teens, and young adults, and both are contraindicated with MAOIs.

Celexa vs. Fluoxetine Drug Summary

Celexa

Celexa (citalopram) is an SSRI antidepressant approved for major depressive disorder in adults. It is taken once daily as a tablet or oral solution, usually starting at 20 mg and increasing to a 40 mg maintenance dose after one week.

Fluoxetine

Fluoxetine is an SSRI antidepressant approved for depression, OCD, bulimia nervosa, and panic disorder, and it is used with olanzapine for bipolar depression. It is taken daily as a capsule, tablet, or oral solution, typically starting at 10 mg and increasing over time, with a once-weekly 90 mg option for some patients.

Celexa vs. Fluoxetine Side Effects

Celexa

Most common
nausea (21%)
somnolence (18%)
insomnia (15%)
dry mouth (20%)

Fluoxetine

Most common
nausea (up to 21%)
somnolence (up to 13%)
insomnia (up to 33%)
headache (up to 21%)

Celexa vs. Fluoxetine Dosage

Celexa

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 20 mg once daily Week 1
Maximum dose 40 mg once daily Week 2 onward
Dose changes 1 increase Every week

Fluoxetine

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 10 mg once daily Week 1
Maximum dose 90 mg once weekly If needed
Dose changes 4 increases Every week

Celexa vs. Fluoxetine Indications

Celexa

Celexa is FDA-approved only for major depressive disorder in adults. Doctors sometimes prescribe it off-label for anxiety-related conditions, though these uses are not FDA-approved.

  • Major depressive disorder (FDA-approved)

  • Generalized anxiety disorder (off-label)

  • Panic disorder (off-label)

  • Obsessive-compulsive disorder (off-label)

Fluoxetine

Fluoxetine has FDA approval for the widest range of conditions among SSRIs, including depression, OCD, bulimia nervosa, and panic disorder, plus pediatric depression and OCD. It is also approved in combination with olanzapine for bipolar depression and treatment-resistant depression.

  • Major depressive disorder in adults and children

  • OCD in adults and children

  • Bulimia nervosa

  • Panic disorder

Celexa vs. Fluoxetine Pros and Cons

Celexa

Celexa has a long track record as one of the most widely prescribed SSRIs, with extensive real-world safety data. Its single approved dose range keeps treatment straightforward, though the QT prolongation warning limits how high the dose can go.

Pros

  • Decades of widespread use with well-established long-term safety data

  • Simple, single maintenance dose with no complex titration schedule

  • Available as both tablet and oral solution

Cons

  • Maximum dose capped at 40 mg/day due to QT prolongation risk

  • Lower 20 mg/day cap required for patients over 60 or with liver impairment

  • Only FDA-approved for one condition, limiting on-label treatment options

  • Not approved for use in children or adolescents

Fluoxetine

Fluoxetine's broad FDA approval across depression, OCD, bulimia nervosa, and pediatric use gives clinicians more on-label flexibility than most SSRIs. Its long-acting metabolite makes missed doses less disruptive, but it also means the drug lingers in the body for weeks after stopping.

Pros

  • Broadest FDA-approved indication list of any SSRI, including pediatric use

  • Long half-life means a missed dose is less likely to cause withdrawal symptoms

  • Once-weekly maintenance dosing option available

Cons

  • Higher rates of insomnia and appetite loss than many other SSRIs

  • Long-acting metabolite can prolong side effects and drug interactions for weeks after stopping

  • More dosing strengths and schedules can make titration more complicated

  • Not approved for use as monotherapy in bipolar disorder

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.